Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019

Published : May-2019

No. of Pages : 168

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Metered Dose Inhaler Devices Overview
3 Products under Development
3.1 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
3.2 Metered Dose Inhaler Devices - Pipeline Products by Territory
3.3 Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Metered Dose Inhaler Devices - Ongoing Clinical Trials
4 Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
4.1 Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
5 Metered Dose Inhaler Devices Companies and Product Overview
5.1 Adamis Pharmaceuticals Corp Company Overview
5.2 Aerophase Inc Company Overview
5.3 AstraZeneca Plc Company Overview
5.4 Circassia Pharmaceuticals Plc Company Overview
5.5 Globe Medical Tech Inc (Inactive) Company Overview
5.6 Lab Automate Technologies Inc Company Overview
5.7 Lupin Pharmaceuticals Inc Company Overview
5.8 Medicom Innovation Partner a/s Company Overview
5.9 Min USA LLC Company Overview
5.10 Pearl Therapeutics Inc Company Overview
5.11 Reciprocal Labs Corp Company Overview
5.12 Rensselaer Polytechnic Institute Company Overview
5.13 Vectura Group Plc Company Overview
5.14 Verona Pharma Plc Company Overview
6 Metered Dose Inhaler Devices- Recent Developments
6.1 Apr 30, 2019: Merck announces first-quarter 2019 financial results
6.2 Apr 24, 2019: Novartis starts 2019 with strong sales and double digit core operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
6.3 Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
6.4 Apr 12, 2019: Cipla launches Niveoli, India's first extra-fine ICS-LABA combination HFA inhaler
6.5 Apr 09, 2019: Novartis continues transformation into a leading medicines company with completion of the Alcon spin-off
6.6 Apr 02, 2019: Alcon announces Timothy Stonesifer as Chief Financial Officer
6.7 Apr 02, 2019: 3M Drug Delivery Systems relocates UK R&D to new, state-of-the-art facility
6.8 Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors
6.9 Mar 26, 2019: Vectura Group 2018 preliminary results
6.10 Mar 22, 2019: Sosei Heptares announces that Ultibro Breezhaler and Seebri Breezhaler launched in China for the treatment of COPD
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
Table 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
Table 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
Table 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
Table 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials
Table 6: Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
Table 7: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
Table 8: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Beclomethasone MDI - Product Status
Table 10: Beclomethasone MDI - Product Description
Table 11: Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Metered Dose Inhaler - Product Status
Table 13: Metered Dose Inhaler - Product Description
Table 14: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Bevespi Aerosphere Inhalation Aerosol - Product Status
Table 16: Bevespi Aerosphere Inhalation Aerosol - Product Description
Table 17: AstraZeneca Plc - Ongoing Clinical Trials Overview
Table 18: Bevespi Aerosphere Inhalation Aerosol - A Phase I, Single-dose, Gamma Scintigraphy Study to Assess the Pulmonary Deposition of Technetium-99m Radiolabelled Budesonide, Glycopyrronium and Formoterol Fumarate MDI in Patients with Moderate to Severe/Very Severe COPD
Table 19: Circassia Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Fliveo - Product Status
Table 21: Fliveo - Product Description
Table 22: Fluticasone propionate/Salmeterol xinafoate pMDI - Product Status
Table 23: Fluticasone propionate/Salmeterol xinafoate pMDI - Product Description
Table 24: Circassia Pharmaceuticals Plc - Ongoing Clinical Trials Overview
Table 25: Fluticasone propionate/Salmeterol xinafoate pMDI - A Phase III Registration Study of Seretide Substitute (PSX2005)
Table 26: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Inhaler - Product Status
Table 28: Inhaler - Product Description
Table 29: Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Ultrasonic Metered Dose Inhaler - Product Status
Table 31: Ultrasonic Metered Dose Inhaler - Product Description
Table 32: Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Albuterol MDI - Product Status
Table 34: Albuterol MDI - Product Description
Table 35: Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Asmair - Product Status
Table 37: Asmair - Product Description
Table 38: Min USA LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Envi - Product Status
Table 40: Envi - Product Description
Table 41: Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: PT001 - Product Status
Table 43: PT001 - Product Description
Table 44: PT010 - Product Status
Table 45: PT010 - Product Description
Table 46: Pearl Therapeutics Inc - Ongoing Clinical Trials Overview
Table 47: PT010 - A Randomized, Double-blind, Multi-center, Parallel-group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects with Moderate to Very Severe COPD (Ethos)
Table 48: Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Connected Metered Dose Inhaler - Product Status
Table 50: Connected Metered Dose Inhaler - Product Description
Table 51: Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Bloom Inhaler - Product Status
Table 53: Bloom Inhaler - Product Description
Table 54: Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Flutiform pMDI - Product Status
Table 56: Flutiform pMDI - Product Description
Table 57: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 58: RPL554 - Metered Dose Inhaler - Product Status
Table 59: RPL554 - Metered Dose Inhaler - Product Description
Table 60: Glossary

1.2 List of Figures
Figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
Figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
Figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
Figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
Figure 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Metered Dose Inhaler Devices - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027